Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I DDI Study of Omega-3 and Atorvastatin
NCT03438955Phase 1Unknown
- Sponsor
- DongKoo Bio & Pharma
- Start
- Feb 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of atorvastatin and omega-3-acid triglycerides in hyperlipidemia and hypertriglyceridemia (2 cohorts), sponsored by DongKoo Bio & Pharma. Primary endpoint: Pharmacokinetic parameters at Day 23. Status: unknown.
02
Drugs
atorvastatinomega-3-acid triglycerides
03
Conditions
hyperlipidemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT03438955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03438955.